Cart
sales@molnova.com
3-(Dodecylamino)propane-1,2-diol
CAS No. 821-91-0
3-(Dodecylamino)propane-1,2-diol( —— )
Catalog No. M37472 CAS No. 821-91-0
3-(Dodecylamino)propane-1,2-diol (3-(Dodecylamino)propane-1,2-diol) is a surfactant that can be used to prepare nanomicelles.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 29 | In Stock |
|
| 50MG | 37 | In Stock |
|
| 100MG | 53 | In Stock |
|
| 200MG | 77 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name3-(Dodecylamino)propane-1,2-diol
-
NoteResearch use only, not for human use.
-
Brief Description3-(Dodecylamino)propane-1,2-diol (3-(Dodecylamino)propane-1,2-diol) is a surfactant that can be used to prepare nanomicelles.
-
Description3-(Dodecylamino)propane-1,2-diol (3-(Dodecylamino)propane-1,2-diol) is a surfactant that can be used to prepare nanomicelles.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number821-91-0
-
Formula Weight259.43
-
Molecular FormulaC15H33NO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOCC(O)CNCCCCCCCCCCCC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Roemerine
Roemerine is a potential active xanthine oxidase(XOD) inhibitor, XOD is a key enzyme in the pathogenesis of hyperuricemia and also a well-known target for the drug development to treat gout.
-
Substance P 1-7
Substance P 1-7 is the major bioactive metabolite formed after proteolytic degradation of the tachykinin substance P (SP)with anti-inflammatory anti-nociceptive and anti-hyperalgesic effects.
-
CP-24879 hydrochlori...
CP-24879 hydrochloride, a Δ5D/Δ6D dual-inhibitor, can significantly reduce intracellular lipid accumulation and inflammatory injury in hepatocytes. CP-24879 hydrochloride exhibits superior antisteatotic and anti-inflammatory actions in fat-1 and ω-3-treated hepatocytes.
